Ukraine health ministry accepts Entolimod dossier for review
Ukraine’s Ministry of Health accepted Valion Bio’s Entolimod dossier for formal review on July 22, 2026.
Technical assessment has started, with initial questions focused on physicochemical characterization of the product intended for potential stockpiling.
A regulatory decision could come as early as Q4 2026, which would be Entolimod’s first national registration if cleared.
VBIO•
